These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6745541)

  • 1. The mouse versus the rat in carcinogen bioassays.
    Clayson DB
    Fundam Appl Toxicol; 1984 Jun; 4(3 Pt 1):499-501. PubMed ID: 6745541
    [No Abstract]   [Full Text] [Related]  

  • 2. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of genetically altered models as replacement for the lifetime mouse bioassay in pharmaceutical development.
    Alden C; Smith P; Morton D
    Toxicol Pathol; 2002; 30(1):135-8. PubMed ID: 11890466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute or grave accentuation.
    Farmer P
    Hum Exp Toxicol; 1996 Dec; 15(12):984-5. PubMed ID: 8981104
    [No Abstract]   [Full Text] [Related]  

  • 5. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How useful are chronic (life-span) toxicology studies in rodents in identifying pharmaceuticals that pose a carcinogenic risk to humans?
    Monro A
    Adverse Drug React Toxicol Rev; 1993; 12(1):5-34. PubMed ID: 8513076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reexamination of false-positive rates for carcinogenesis studies.
    Haseman JK
    Fundam Appl Toxicol; 1983; 3(4):334-9. PubMed ID: 6628896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic aspects of carcinogenesis and carcinogen testing.
    O'Brien SJ; Rice MC
    J Toxicol Environ Health; 1979 Jan; 5(1):69-81. PubMed ID: 423307
    [No Abstract]   [Full Text] [Related]  

  • 9. Meeting new challenges in industrial toxicology.
    Reinhardt CF
    J Toxicol Sci; 1987 May; 12(2):235-41. PubMed ID: 3625819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of the Gene-Tox Carcinogen Data Base.
    Nesnow S; Bergman H
    Mutat Res; 1988; 205(1-4):237-53. PubMed ID: 3285189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
    Ashby J; Paton D
    Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The decision-point approach for systematic carcinogen testing.
    Weisburger JH; Williams GM
    Food Cosmet Toxicol; 1981 Oct; 19(5):561-6. PubMed ID: 7308902
    [No Abstract]   [Full Text] [Related]  

  • 13. Current and emerging challenges in toxicopathology: carcinogenic threshold of phenobarbital and proof of arsenic carcinogenicity using rat medium-term bioassays for carcinogens.
    Fukushima S; Morimura K; Wanibuchi H; Kinoshita A; Salim EI
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):225-9. PubMed ID: 15993454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A viewpoint on the extrapolation of toxicological data from animals to man.
    Feron VJ; van Bladeren PJ; Hermus RJ
    Food Chem Toxicol; 1990 Nov; 28(11):783-8. PubMed ID: 2272554
    [No Abstract]   [Full Text] [Related]  

  • 15. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 1/2. A multi-factor ranking scheme for comparing the carcinogenic activity of chemicals.
    Nesnow S
    Mutat Res; 1990 Sep; 239(2):83-115. PubMed ID: 2385240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of investigative toxicology in pharmaceutical industry.
    Harpur ES; Bonner FW
    Arch Toxicol Suppl; 1994; 16():176-82. PubMed ID: 8192579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between carcinogenic potency and tumor pathology in rodent carcinogenesis bioassays.
    Gold LS; Ward JM; Bernstein L; Stern B
    Fundam Appl Toxicol; 1986 May; 6(4):677-90. PubMed ID: 3710036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys.
    Gold LS; Manley NB; Slone TH; Ward JM
    Toxicol Pathol; 2001; 29(6):639-52. PubMed ID: 11794380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can systems toxicology identify common biomarkers of non-genotoxic carcinogenesis?
    Plant N
    Toxicology; 2008 Dec; 254(3):164-9. PubMed ID: 18674585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the rodent bioassays currently being conducted on 44 chemicals: a RASH analysis to predict test results from the National Toxicology Program.
    Jones TD; Easterly CE
    Mutagenesis; 1991 Nov; 6(6):507-14. PubMed ID: 1800899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.